United States · FDA National Drug Code directory
Midazolam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70069-816_0bbe4e90-4c26-cbbb-e063-6294a90aad1b
- Product NDC
- 70069-816
- Form
- INJECTION, SOLUTION
- Composition / generic term
- midazolam hydrochloride
- Labeler
- SOMERSET THERAPEUTICS, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231205
- Source listing expiry
- 20261231
Source-listed ingredients
- MIDAZOLAM HYDROCHLORIDE — 2 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (70069-816-10) / 2 mL in 1 VIAL · 70069-816-10
- 25 VIAL in 1 CARTON (70069-816-25) / 2 mL in 1 VIAL · 70069-816-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →